Genotoxic and Cytotoxic Damage by Cyclophosphamide and Adriamycin as a Response to Treatment in Breast Cancer Patients: Pilot Study

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.net/journal/jct
E-mail: [email protected]

Citations

"Genotoxic and Cytotoxic Damage by Cyclophosphamide and Adriamycin as a Response to Treatment in Breast Cancer Patients: Pilot Study"
written by Jimena Garibay-Garcia, Fernando Mejia-Sanchez, Eduardo Ramírez-San-Juan, Miriam V. Flores-Merino, Julieta Castillo-Cadena,
published by Journal of Cancer Therapy, Vol.6 No.2, 2015

has been cited by the following article(s):

[1]	Polymorphisms GSTT1, GSTM1 and GSTP1 influence in magnitude of DNA damage induced by cyclophosphamide
	2018

[2]	MODIFYING EFFECT OF VIT. E ON CYCLOPHOSPHAMIDE (CP) DRUGINDUCED, HEMATOLOGICAL PARAMETERS AND CYTOTOXIC EFFECT IN MALE ALBINO RATS (RATUSRATUS)
	European Journal of Research, 2017

[3]	In vitro evaluation of the mutagenic and cytostatic effect of Tamaron, Lannate and Manzate alone and in mixture
	Journal of Leisure Research, 2016

Top

[1]	Micronucleus evaluation of remifentanil exposure Journal of Research in Pharmacy, 2025 DOI:10.12991/jrespharm.1634413

[2]	In vitroevaluation of the mutagenic and cytostatic effect of Tamaron, Lannate and Manzate alone and in mixture Journal of Environmental Science and Health, Part B, 2016 DOI:10.1080/03601234.2016.1198636